WILLOW BIOSCIENCES TO PRESENT AT THE EMERGING GROWTH CONFERENCE ON AUGUST 9

Rhea-AI Summary

Willow Biosciences to provide business update at the Emerging Growth Conference on August 9

Positive

• Willow Biosciences Inc. will present at the Emerging Growth Conference on August 9, where President and CEO Dr. Chris Savile will provide an update on the company's business. The live virtual presentation will be available to all investors.

Negative

• None.

President and CEO Dr. Chris Savile to provide business update at event open to all investors

SUNNYVALE, Calif., Aug. 2, 2023 /PRNewswire/ - Willow Biosciences Inc. ("Willow") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent and sustainable functional ingredients announces that it will present at the upcoming Emerging Growth Conference August 8-9, 2023.

President and CEO Dr. Chris Savile will provide an update on Willow's business during a live virtual presentation at 2:55 p.m. Eastern Time on Wednesday, August 9. The live presentation is available for all investors.

RSVP: Please register here to ensure you are able to attend the conference and receive any updates on the company that are released.

If attendees are not able to join the live event on August 9, an archived webcast will also be available on the EmergingGrowth.com website and on the Emerging Growth YouTube Channel afterward.

About the Emerging Growth Conference

The Emerging Growth conference is an effective way for public companies to present and communicate their new products, services and other major announcements to the investment community from the convenience of their office, in a time efficient manner.

The Conference focus and coverage includes companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long term growth. Its audience includes potentially tens of thousands of Individual and Institutional investors, as well as Investment advisors and analysts.

About Willow Biosciences Inc.

Willow develops and produces precision fermented functional ingredients for the health and wellness, food and beverage and personal care markets. Willow's FutureGrown™ and BioOxi™ platforms enable large-scale production with sustainability at its core. Willow's R&D team has a proven track record of developing and commercializing bio-based manufacturing processes and products to benefit our B2B partners and their customers. For more information, visit www.willowbio.com.

FutureGrown™ and BiOxi™ are registered trademarks of Willow Biosciences Inc. All other trademarks are trademarks of their respective holders.

View original content to download multimedia:https://www.prnewswire.com/news-releases/willow-biosciences-to-present-at-the-emerging-growth-conference-on-august-9-301891059.html

SOURCE Willow Biosciences Inc.

FAQ

When and where will Willow Biosciences provide a business update?

Willow Biosciences will provide a business update at the Emerging Growth Conference on August 9 through a live virtual presentation.

Who will be presenting the business update?

President and CEO Dr. Chris Savile will be presenting the business update.

Who can attend the live virtual presentation?

The live virtual presentation is available for all investors.

Where can I find the archived webcast of the event?

The archived webcast will be available on the EmergingGrowth.com website and on the Emerging Growth YouTube Channel.